Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
NCT05392374 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-05-26
Summary
This is an intermediate-size expanded access protocol to provide ONC201 to patients with diffuse intrinsic pontine gliomas who cannot access ONC201 through clinical trials.
Conditions
Interventions
- DRUG
-
ONC201
ONC201 is an oral, small molecule selective antagonist of DRD2
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Years
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas
NCT05913037 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
NCT01106794 ·Status: RECRUITING
-
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496 ·Status: RECRUITING
-
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
NCT06014905 ·Status: RECRUITING ·Phase: PHASE1
-
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
NCT02211768 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200 ·Status: COMPLETED
-
Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1
NCT05199376 ·Status: RECRUITING ·Phase: NA
-
Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma
NCT02077543 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Sphenoorbital Meningioma Management.
NCT04710485 ·Status: UNKNOWN
-
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
NCT02300506 ·Status: COMPLETED
-
Natural History of Patients With Brain and Spinal Cord Tumors
NCT00009035 ·Status: COMPLETED
-
Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes
NCT06116903 ·Status: RECRUITING ·Phase: NA
-
Confocal Laser Endomicroscopy for Brain Tumors
NCT02240758 ·Status: TERMINATED ·Phase: PHASE1
-
MRI-Guided Focused Ultrasound Feasibility Study for Brain Tumors
NCT00147056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
NCT02544022 ·Status: RECRUITING
-
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas
NCT05130866 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
NCT05565118 ·Status: RECRUITING ·Phase: PHASE1
-
Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
NCT03997136 ·Status: UNKNOWN
-
Glioma Brain Tumours - E12513 - SensiScreen Glioma
NCT04539431 ·Status: UNKNOWN
-
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
NCT03102203 ·Status: UNKNOWN
-
Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas
NCT05259332 ·Status: UNKNOWN
-
Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
NCT03591861 ·Status: TERMINATED ·Phase: NA
-
Developing Criteria for Cortical Resections
NCT00152659 ·Status: COMPLETED
-
Genetic and Molecular Characterization of Nervous System Lesions
NCT06314607 ·Status: RECRUITING
-
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
NCT02851706 ·Status: COMPLETED